By Dani Kass ( January 28, 2019, 5:57 PM EST) -- A Johnson & Johnson unit wasn't infringing three of MorphoSys AG's patents with its multiple myeloma drug Darzalex, and even if it had been, the patent claims aren't enforceable, a Delaware federal judge said in an order unsealed Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.